Fibroblast-mediated delivery of GDNF induces neuronal-like outgrowth in PC12 cells

Otology and Neurotology

Volumn 29, Issue 4, 2008, Pages 475-481

  Wissel, Kirsten ^a   Stöver, Timo ^a   Hofmann, Nicola Sabine ^b   Chernajovsky, Yuti ^c   Daly, Gordon ^c   Sasse, Susanne ^a   Warnecke, Athanasia ^a   Lenarz, Thomas ^a   Gross, Gerhard ^d   Hoffmann, Andrea ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Conditional lentiviral expression; GDNFVNeuronal like outgrowth; NIH3T3; PC12

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; RECOMBINANT GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; RECOMBINANT GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN 3T3; CELL STRAIN HEK293; CISTRON; CONTROLLED STUDY; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL DIFFERENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE VECTOR; GENETICS; LENTIVIRINAE; METABOLISM; NERVE CELL; NERVE FIBER; PHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; AXONS; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEINS; LENTIVIRUS; MICE; NEURONS; NIH 3T3 CELLS; PC12 CELLS; RATS;

EID: 47249164690     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318164d110     Document Type: Article

References (40)

1. Spoendlin H. Factors inducing retrograde degeneration of the cochlear nerve. Ann Otol Rhinol Laryngol 1984;112:76-82.
2. Webster M, Webster DB. Spiral ganglion neuron loss following organ of Corti loss: a quantitative study. Brain Res 1981;212:17-30.
3. Leake PA, Hradek GT, Rebscher SJ, Snyder RL. Chronic intraco-chlear electrical stimulation induces selective survival of spiral ganglion neurons in neonatally deafened cats. Hear Res 1991;54: 251-71.
4. Matsui JI, Parker MA, Ryals BM, Cotanche DA. Regeneration and replacement in the vertebrate inner ear. Drug Discov Today 2005; 10:1307-12.
5. Loizou PC, Mani A, Dorman MF. Dichotic speech recognition in noise using reduced spectral cues. J Acoust Soc Am 2003;114:475-83.
6. Lenarz T, Stover T, Buechner A, et al. Temporal bone results and hearing preservation with a new straight electrode. Audiol Neurootol 2006;11:34-41.
7. Nadol JB Jr. Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation. Otolaryngol Head Neck Surg 1997;117:220-8.
8. Incesulu A, Nadol JB Jr. Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Ann Otol Rhinol Laryngol 1998;107:906-11.
9. Buechner A, Frohne-Buechner C, Gaertner L, Lesinski-Schiedat A, Battmer RD, Lenarz T. Evaluation of advanced bionics high resolution mode. Int J Audiol 2006;45:407-16.
10. Paasche G, Bockel F, Tasche C, Lesinski-Schiedat A, Lenarz T. Changes of postoperative impedances in cochlear implant patients: the short-term effects of modified electrode surfaces and intraco-chlear corticosteroids. Otol Neurotol 2006;27:639-47.
11. Agerman K, Canlon B, Duan M, Ernfors P. Neurotrophins, NMDA receptors, and nitric oxide in development and protection of the auditory system. Ann N Y Acad Sci 1999;884:131-42.
12. Gillespie LN, Shepherd RK. Clinical application of neurotrophic factors: the potential for primary auditory neuron protection. Eur J Neurosci 2005;22:2123-33.
13. Wise AK, Richardson R, Hardman J, Clark G, O'leary S. Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3. J Comp Neurol 2005;27:147-65.
14. Richardson RT, Noushi F, O'Leary S. Inner ear therapy for neural preservation. Audiol Neurootol 2006;11:343-56.
15. Kanzaki S, Stover T, Kawamoto K, et al. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J Comp Neurol 2002;454:350-60.
16. -amagati T, Miller JM, Ulfendahl M, et al. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycin-deafened guinea pigs. J Neurosci Res 2004; 78:75-86.
17. Shepherd RK, Coco A, Epp SB, Crook JM. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J Comp Neurol 2005;486:145-58.
18. Coco A, Epp SB, Fallon JB, Xu J, Millard RE, Shepherd RK. Does cochlear implantation and electrical stimulation affect residual hair cells and spiral ganglion neurons? Hear Res 2007;225:60-70.
19. Kishino A, Katayama N, Ishige Y, et al. Analysis of effects and pharmocokinetics of subcutaneously administered BDNF. Neuroreport 2001;12:1067-72.
20. Jero J, Mhatre AN, Tseng CJ, et al. Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 2001;12:539-48.
21. Shoji F, Yamasoba T, Magal E, Dolan DF, Altschuler RA, Miller JM. Glial cell line-derived neurotrophic factor has a dose dependent influence on noise-induced hearing loss in the guinea pig cochlea. Hear Res 2000;142:41-55.
22. Shinohara T, Bredberg G, Ulfendahl M, et al. Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 2002;5:1657-60.
23. Kawamoto K, Yagi M, Stöver T, Kanzaki S, RaphaelY. Hearing and hair cells are protected by adenoviral gene therapy with TGFβ-1 and GDNF. Mol Ther 2003;7:484-92.
24. Nakaizumi T, Kawamoto K, Minoda R, RaphaelY. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 2004;9:135-43.
25. Izumikawa M, Minoda R, Kawamoto K, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005;11:271-6.
26. Ishimoto S, Kawamoto K, Stöver T, Kanzaki S,Yamasoba T, RaphaelY. A glucocorticoid reduces adverse effects of adenovirus vectors in the cochlea. Audiol Neurootol 2003;8:70-9.
27. Ruitenberg MJ, Plant GW, Hamers FP, et al. Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheath-ing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J Neurosci 2003;23:7045-58.
28. Blits B, Kitay BM, Farahvar A, Caperton CV, Dietrich WD, Bunge MB. Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci 2005;23:313-24.
29. ChernajovskyY, Gould DJ, Podhajcer OL. Gene therapy for autoimmune diseases: quo vadis? Nat Rev Immunol 2004;4:800-11.
30. Garrels JI, Schubert D. Modulation of protein synthesis by nerve growth factor. J Biol Chem 1979;254:7978-85.
31. Luckenbill-Edds L, Van Horn C, Greene LA. Fine structure of initial outgrowth of processes induced in a pheochromocytoma cell line (PC12) by nerve growth factor. J Neurocytol 1979;8: 493-511.
32. Salmon P, Oberholzer J, Occhiodoro T, Morel P, Lou J, Trono D. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2000;2:404-14.
33. Kapur TA, Shoichet MS. Chemically-bound nerve growth factor for neural tissue engineering applications. J Biomater Sci Polym Ed 2003;14:383-94.
34. Staecker H, Kopke R, Malgrange B, Lefebvre P, Van de Water TR. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996;7:889-94.
35. Stöver T,Yagi M, RaphaelY. Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 2000;7:377-83.
36. Lalwani AK, Jero J, Mhatre AN. Current issues in cochlear gene transfer. Audiol Neurootol 2002;7:146-51.
37. Okano T, Nakagawa T, Kita T, Endo T, Ito J. Cell-gene delivery of brain-derived neurotrophic factor to the mouse inner ear. Mol Ther 2006;14:866-71.
38. Barnett MW, Fisher CE, Perona-Wright G, Davies JA. Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan. J Cell Sci 2002;115: 4495-503.
39. -likoski J, Pirvola U, Virkkala J, et al. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998;124:17-26.
40. Rejali D, Lee VA, Abrashkin KA, Humayun N, Swiderski DL, RaphaelY. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 2007;228:180-7.